Advertisement

Search Results for "Exenatide Zeta Potential"

17:34 EDT 24th May 2013 | BioPortfolio

Original Source: PARTICLE ANALYTICAL ApS

PARTICLE ANALYTICAL is a dynamic company devoted to supporting customers within the field of particle science.We focus first and foremost on the pharmaceutical industry We offer a broad range of particle analytical methods We support the following areas; R&D, production and quality assuranceMalvern Instruments has approved PARTICLE ANALYTICAL as a third party independent analysis lab. Read a PDF version of the press release here (35 KB)Malvern is a leading supplier of analytical solutions for parti...

Matching Channels

ETS2101

ETS2101 (dexanabinol) is a synthetic cannabinoid previously studied in trauma patients. Its anti-cancer potential was identified by e-Therapeutics’ network pharmacology platform. This revealed...

Early Embryo Viability Assessment Test (Eeva)

Auxogyn’s non-invasive Early Embryo Viability Assessment Test (Eeva) may improve in vitro fertilization (IVF) outcomes by providing IVF clinics and patients with objective information on embry...

Pain

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...

UGenRA - Genitourinary cancer array

UGenRA is a CGI custom-designed oligonucleotide array designed to detect gains and losses of genomic material in endometrial, ovarian, and cervical cancers. Endometrial hyperplasia is a precursor le...

Metabotropic Glutamate Receptor 4 (mGluR4)

Metabotropic glutamate receptor 4 is a protein that in humans is encoded by the GRM4 gene. Together with GRM6, GRM7 and GRM8 it belongs to group III of the metabotropic glutamate receptor famil...

Matching News

Extended release exenatide outperforms twice daily regimen

Once-weekly extended-release exenatide is a more effective treatment than twice-daily exenatide at improving glucose control among Japanese individuals with diabetes, report researchers.

NanoPlus DLS Nano Particle Size and Zeta Potential Analyzer

Micromertitics Particulate Systems gains exclusive global distribution rights for the NanoPlus DLS Nano Particle Size and Zeta Potential Analyzer.

Exenatide vs Metformin: Endothelial Activity in Prediabetes

Can exenatide help prevent T2DM? Cardiovascular Diabetology

Determining Predictors of Response to Exenatide in T2DM

Which patients will have the best response from exenatide? Journal of the American Pharmacists Association

B-MS/AZ take over UK exenatide sales

B-MS/AZ take over UK exenatide sales

Exenatide Beats Glimepiride in Type 2 Diabetes

In patients with type 2 diabetes not controlled with metformin, more of those receiving exenatide than glimepiride achieved target glycated hemoglobin levels. Medscape Medical News

HEI wins Integral Tech Zeta certification

HEI, a printed circuit board fabricator, has received Zeta certification from Integral Technology, which manufactures HDI electronic materials for the PCB industry.

Exenatide more effective than insulin detemir: study

NEW YORK (Reuters Health) - Exenatide is more effective than insulin detemir when added to oral glucose-lowering therapies, European researchers say.

Matching PubMed Articles

Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials.

Introduction: There is a need for new and improved treatments for type 2 diabetes. Glucagon-like peptide 1 (GLP-1) is a gut hormone that stimulates insulin secretion and the levels of GLP-1 can be inc...

Determination of zeta potential in Planctomycetes and its application in heavy metals toxicity assessment.

Zeta potential of Planctomycetes was evaluated under different environmental conditions and correlated to cell viability. Phylogenetically distinct strains of the Planctomycetes presented different ne...

Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes.

Abstract Objective: To investigate the real-world use of combination insulin glargine/exenatide therapy for type 2 diabetes mellitus (T2DM) and associated treatment persistence and glycemic contr...

Exenatide extended-release: a review of its use in type 2 diabetes mellitus.

Subcutaneous exenatide extended-release (ER; Bydureon™; also known as exenatide once weekly), a glucagon-like peptide-1 receptor agonist, provides a convenient, simple, once-weekly regimen that is a...

Acute Pancreatitis in Type 2 Diabetes Treated with Exenatide or Sitagliptin: A Retrospective Observational Pharmacy Claims Analysis.

AbstractObjective. Cases of acute pancreatitis (AP) have been reported in association with exenatide, sitagliptin, and type 2 diabetes without use of these medications. It remains unknown whether exen...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement